Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 /PRNewswire/ -- Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...
SpaceNews reported that Schott introduced Solar Glass exos, a new cover glass developed for next-generation satellite solar cells. The material was created with AZUR Space Solar Power GmbH and ...
– SCHOTT® Solar Glass exos provides enhanced radiation resistance and optical performance for simple silicon cells up to III-V multijunction satellite solar cells. – Jointly developed with ...
The cell and gene therapy quality control and analytics market is rapidly accelerating as AI-driven tools, advanced testing technologies, and global industry partnerships enhance accuracy, speed, and ...
Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback